
Key Points
- 01U.S. court grants WuXi AppTec a preliminary injunction on a Pentagon designation
- 02Judge says Pentagon misread evidence in labeling WuXi a “Chinese military company”
- 03Court cites irreparable commercial harm to WuXi’s U.S. operations and revenue
- 04Injunction is temporary and does not remove WuXi from the Section 1260H list
Court halts enforcement of WuXi AppTec military label
U.S. District Judge James Boasberg has granted WuXi AppTec a preliminary injunction that temporarily bars the Department of Defense from enforcing its June designation of the company as a “Chinese military company.” The order concerns WuXi’s inclusion on the Pentagon’s Section 1260H list and pauses the practical effect of that designation while litigation continues.
The ruling does not permanently resolve the dispute or remove WuXi from the list but prevents the Pentagon, for now, from treating WuXi as subject to that label in a way that would trigger legal or commercial consequences. The decision applies only to WuXi and does not change the status of other companies on the list.
Judge faults Pentagon’s evidentiary basis
In his opinion, Judge Boasberg found that the Pentagon had misread or mischaracterized parts of the evidence used to justify adding WuXi to the Section 1260H list. A central example was the treatment of data about an investment fund’s holdings in WuXi.
The court said the Defense Department had confused the percentage of the fund’s net asset value invested in WuXi with the percentage of WuXi’s equity owned by the fund. The opinion described this misunderstanding as “flat-out wrong,” underscoring the court’s view that the designation rested on a flawed evidentiary foundation.
Finding of irreparable commercial harm
The court concluded that WuXi had already suffered irreparable commercial harm in the United States as a result of the designation. The opinion highlighted that WuXi operates six U.S. facilities and employs about 450 people in the country.
WuXi serves more than 1,000 U.S. customers, and U.S.-based clients accounted for roughly 70% of the company’s approximately US$6.7 billion in global revenue last year, the opinion noted. These figures were cited as evidence that a continuation of the designation could significantly disrupt a large share of WuXi’s business.
Scope and limits of the injunction
The preliminary injunction is expressly temporary. It does not strike WuXi from the Section 1260H list and does not bar the Pentagon from attempting to redesignate the company in the future if supported by different evidence.
Other companies on the Section 1260H list, including firms such as Alibaba, Baidu and BYD, are unaffected by this order and remain subject to their existing designations. The Pentagon has declined to discuss the ruling or to say whether it plans to appeal, citing a policy of not commenting on ongoing litigation.
Key Takeaways
- 01The court’s injunction offers WuXi short-term relief from the immediate impact of the “Chinese military company” label but leaves its long-term status unresolved.
- 02Judicial criticism of the Pentagon’s evidentiary approach may influence how future Section 1260H designations are built and scrutinized.
- 03WuXi’s large U.S. customer base and revenue exposure were central to the court’s finding that the designation risked serious, irreparable commercial harm.
References
- https://www.scmp.com/news/us/article/3363369/us-judge-blocks-pentagons-chinese-military-label-wuxi-apptec
- https://asia.nikkei.com/politics/international-relations/us-china-tensions/us-court-pauses-pentagon-s-blacklisting-of-china-s-wuxi-apptec
- https://finance.yahoo.com/healthcare/articles/judge-blocks-us-decision-add-192006082.html
- https://www.channelnewsasia.com/east-asia/us-judge-blocks-pentagon-listing-wuxi-chinese-military-linked-firm-6306941